Gene Abnormality clinical trials at UCSF
1 research study open to eligible people
Gene abnormality is when there's a problem with a person's DNA that can lead to health issues. UCSF is recruiting participants for a clinical trial called "Neonatal Seizure Registry, Genetics of Post-Neonatal Epilepsy." This study is for parent-child trios from the Neonatal Seizure Registry to learn more about gene abnormalities and their relationship to epilepsy.
Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy
open to all eligible people
The NSR-GENE study is a longitudinal cohort study of approximately 300 parent-child trios from the Neonatal Seizure Registry and participating site outpatient clinics that aims to evaluate whether and how genes alter the risk of post-neonatal epilepsy among children with acute provoked neonatal seizures. The researchers aim to develop prediction rules to stratify neonates into low, medium, and high risk for post-neonatal epilepsy based on clinical, electroencephalogram (EEG), magnetic resonance imaging (MRI), and genetic risk factors.
San Francisco, California and other locations
Our lead scientists for Gene Abnormality research studies include Hannah C Glass, MDCM, MAS.